Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is one of the most common types of primary liver cancer and remains a leading cause of cancer-related deaths worldwide. While traditional approaches like surgical resection and tyrosine kinase inhibitors struggle against the tumor’s immune evasion, monoclonal...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2025-01-01
|
Series: | Genomics & Informatics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s44342-024-00033-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|